Clinical Trials Directory

Trials / Completed

CompletedNCT01941706

Preventing Depression in People With Epilepsy: an Extension of Project UPLIFT

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Emory University · Academic / Other
Sex
All
Age
21 Years
Healthy volunteers
Not accepted

Summary

Project UPLIFT, a home-based treatment for depression in people with epilepsy, was designed to be delivered to groups by telephone or Web. The Project UPLIFT intervention materials were demonstrated to be effective in treating depression among people with epilepsy in Georgia. This project will assess whether the materials are also effective for preventing depression among people with epilepsy, and will extend the project beyond Georgia to Michigan, Texas, and Washington.

Detailed description

The study is a pilot test of Project UPLIFT for depression prevention during which the acceptability and estimates of effectiveness of the intervention, presented in the Web and telephone modes, are assessed.

Conditions

Interventions

TypeNameDescription
BEHAVIORALProject UPLIFTDeveloped for home-based treatment of depression in people with epilepsy, Project UPLIFT is based upon Mindfulness-based Cognitive Therapy for depression. It includes 8 modules, group-delivered by either telephone or Web. Trainees and people with epilepsy co-facilitate the groups, supervised by a licensed mental health professional.The co-facilitators are trained and supervised by the Principal Investigator, a Georgia-licensed clinical psychologist and Associate Professor of Behavioral Science and of Epidemiology in public health. Activities are designed to increase knowledge about depression; monitoring, challenging, and changing thoughts; coping and relaxing; attention and mindfulness; focusing on pleasure; the importance of reinforcement, and preventing relapse.

Timeline

Start date
2009-10-01
Primary completion
2011-12-01
Completion
2012-06-01
First posted
2013-09-13
Last updated
2014-02-12

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01941706. Inclusion in this directory is not an endorsement.